Literature DB >> 16733847

Relationships between mucinous gastric carcinoma, MUC2 expression and survival.

Emmanuelle Leteurtre1, Farid Zerimech, Guillaume Piessen, Agnes Wacrenier, Xavier Leroy, Marie-Christine Copin, Christophe Mariette, Jean-Pierre Aubert, Nicole Porchet, Marie-Pierre Buisine.   

Abstract

AIM: To investigate the expression of the four secreted gel-forming mucins (MUC2, MUC5AC, MUC5B and MUC6) in a series of gastric carcinomas, classified according Lauren's, Mulligan's, WHO and Goseki's classifications, with special attention to all the different components (major and minor) present in tumors and to follow up clinical data.
METHODS: Expression of MUC2, MUC5AC, MUC5B and MUC6 was investigated using immunohistochemistry and in situ hybridization.
RESULTS: Expression of secreted gel-forming mucins in gastric carcinoma was particularly complex, each mucin being not restricted to any histopathological type even considering all components (major and minor) present in a given tumor. There was a worst survival in patients with a higher content of mucus (Goseki II or IV) and high positive MUC2 expression.
CONCLUSION: Complexity of mucin gene expression patterns in gastric cancer may reflect a precise state of differentiation at the cell level not recognized in used morphologic classification systems. High expression of MUC2 was nevertheless associated with mucinous subtype of the WHO classification and with group II of Goseki's classification identified by the major component of a particular tumor. The quantity and quality of mucus were related to survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733847      PMCID: PMC4087862          DOI: 10.3748/wjg.v12.i21.3324

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  [MUC genes: mucin or not mucin? That is the question].

Authors:  Nicole Porchet; Jean-Pierre Aubert
Journal:  Med Sci (Paris)       Date:  2004-05       Impact factor: 0.818

2.  Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma.

Authors:  Stephan E Baldus; Stefan P Mönig; Verena Arkenau; Franz-Georg Hanisch; Paul M Schneider; Juergen Thiele; Arnulf H Hölscher; Hans P Dienes
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

3.  Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.

Authors:  João Pinto-de-Sousa; Leonor David; Celso A Reis; Raquel Gomes; Liliana Silva; Amadeu Pimenta
Journal:  Virchows Arch       Date:  2001-10-23       Impact factor: 4.064

Review 4.  Histogenesis and biologic behavior of gastric carcinoma.

Authors:  R M Mulligan
Journal:  Pathol Annu       Date:  1972

5.  Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma.

Authors:  N Goseki; T Takizawa; M Koike
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

6.  Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.

Authors:  Hong-Kai Zhang; Qiu-Min Zhang; Tie-Hua Zhao; Yuan-Yuan Li; Yong-Fen Yi
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

7.  Prognostic significance of mucin expression in gastric carcinoma.

Authors:  Belma Kocer; Atilla Soran; Gulten Kiyak; Sibel Erdogan; Abdullah Eroglu; Betül Bozkurt; Cem Solak; Omer Cengiz
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

8.  MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach.

Authors:  C De Bolós; M Garrido; F X Real
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

9.  MUC2 is a molecular marker for pseudomyxoma peritonei.

Authors:  Jerome T O'Connell; Cammy M Hacker; Sanford H Barsky
Journal:  Mod Pathol       Date:  2002-09       Impact factor: 7.842

10.  Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.

Authors:  S B Ho; L L Shekels; N W Toribara; Y S Kim; C Lyftogt; D L Cherwitz; G A Niehans
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

View more
  6 in total

1.  Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro.

Authors:  Li-Duan Zheng; Chun-Lei Yang; Teng Qi; Meng Qi; Ling Tong; Qiang-Song Tong
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

2.  The complex intratumoral heterogeneity of colon cancer highlighted by laser microdissection.

Authors:  David Buob; Harold Fauvel; Marie-Pierre Buisine; Stéphanie Truant; Christophe Mariette; Nicole Porchet; Agnès Wacrenier; Marie-Christine Copin; Emmanuelle Leteurtre
Journal:  Dig Dis Sci       Date:  2011-12-25       Impact factor: 3.199

3.  The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.

Authors:  Fulya Oz Puyan; Nuray Can; Filiz Ozyilmaz; Ufuk Usta; Necdet Sut; Ebru Tastekin; Semsi Altaner
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-10       Impact factor: 4.553

4.  Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas.

Authors:  Jung-Soo Pyo; Young San Ko; Guhyun Kang; Dong-Hoon Kim; Woo Ho Kim; Byung Lan Lee; Jin Hee Sohn
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-05       Impact factor: 4.553

Review 5.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

6.  Mechanisms of coagulative necrosis in malignant epithelial tumors (Review).

Authors:  Rosario A Caruso; Giovanni Branca; Francesco Fedele; Eleonora Irato; Giuseppe Finocchiaro; Antonio Parisi; Antonio Ieni
Journal:  Oncol Lett       Date:  2014-07-11       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.